We offer fair terms, capital, and support without interference.
We are the leading provider of funding solutions for life sciences innovation.
Funding the future of biopharma
Founded in 1996, Royalty Pharma has pioneered the royalty funding market and continued to innovate in life science funding.
Life sciences partner of choice
We are the global leader in biopharma royalty transactions, with a diverse portfolio of leading therapies.
Defying convention with new ideas
We create tailored funding solutions that advance our partners’ core mission.
We go wherever the science takes us
Pioneering the royalty market for 25+ years
Innovating new funding solutions, including synthetic royalties
One Royalty Pharma team at the center of every transaction
Long-tenured expert team with deep scientific experience
Open business model: tailored solutions and true partnerships
Proud of partnerships that grow over multiple transactions
Platform built to scale with the royalty market
Team and process growing to address the large opportunity ahead
Exhaustive diligence process sharpened over decades
Able to integrate and interpret a broad and expanding information set
Leveraging big data through strategy & analytics
Unique platform for clinical trial analysis and market evaluation
Innovating and collaborating to make a positive impact on society
The foundation of our culture rests on teamwork, critical thinking, innovation and the pursuit of excellence. We are nimble. We are laser-focused on making good investments in high quality, long duration therapies that generate attractive returns for our shareholders. By collaborating to accelerate innovation, we enable our partners to transform patient lives.
At Royalty Pharma we reward creative thinking – and new perspectives on old challenges
We hire talented people and invest in their growth to build engaged and diverse teams that are well-positioned to succeed.